Chordia Therapeutics Inc.

190A・Growth Market・Pharmaceuticals

Official website

Chordia Therapeutics Inc.

190A・Growth Market・Pharmaceuticals

Official website

Chordia Therapeutics Inc.190A

Reference Indicators

Market Cap

59¥100M

P/E (Forecast)

—

P/B

2.2x

Dividend Yield (Forecast)

0.00%

ROE

-73.4%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2024Aug 2024	2025Aug 2025
SG&A Expenses	301	364
Operating Income	-1,801	-1,789
Non-operating Income	17	24
Non-operating Expenses	41	3
Ordinary Income	-1,824	-1,769
Extraordinary Losses	—	13
Pre-tax Income	-1,824	-1,783
Income Taxes	2	2
Net Income	-1,827	-1,785
EBITDA	-1,797	-1,787
ROA	-39.4%	-66.6%
ROE	-43.9%	-73.4%